Home›People›Neil Solomons
Neil Solomons

Neil Solomons

Director at Maxymune Therapeutics.

Director
Updated Nov 10, 2026·Latest SEC filing Jun 3, 2026·Suggest an edit

About Neil Solomons

Neil Solomons is a director at Maxymune Therapeutics.

Experience

This experience comes from Neil Solomons's profile and from SEC filings. For roles taken from filings, the years are when the filings name Neil Solomons in the role, so the role may have started earlier or lasted longer.

Boulevard Bio Current
Chief Medical Officer
2026 – Present
Maxymune Therapeutics, Inc. Current
Member Board of Directors
2024 – Present · Los Altos, CA
Develops treatments for people with immune system disorders.
Neil Solomons Consulting Inc
Immunology, inflammation, rare disease and nephrology clinical and regulatory consultant
2022 – 2026
Aurinia Pharmaceuticals Inc.
Chief Medical Officer and Co-Founder
2013 – 2022
Vifor
Vice President (VP) Clinical Development
2005 – 2013
Roche Pharmaceuticals
EU Head of Medical Affairs
1998 – 2004
NHS
Anaesthetics and Intensive Care
1991 – 1998

Key Colleagues at Startups

The people Neil Solomons works with at each company, as listed on that company's latest Form D.

Maxymune Therapeutics, Inc. · Form D/A, Jun 3, 2026
Tatjana Naranda
Tatjana Naranda
President, Chief Operating Officer and director
Gordon Ringold
Gordon Ringold
Executive Chairman of the Board

Sources

  1. SECMaxymune Therapeutics, Inc. Form D/A, filed Jun 3, 2026